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ture,1 ischemia,2 hypoxia,3 and depletion of adenosine
triphosphate.4 The exact mechanism of this protective
effect is not known, but it is thought that this is partly due
to the ability of Hsp to act as molecular chaperones by
binding to denaturing proteins to protect their native
structure. In addition to increases in expression of Hsp,
heat shock causes several other changes such as
increased antioxidant capacity,5 improved preservation of
high-energy phosphates,6 and activation of K+ chan-
nels,7,8 which could contribute to the protective effect.
Despite the controversy surrounding the protective
effects of Hsp70, the degree of postischemic recovery
The accumulation of 70-kd heat shock protein (Hsp70)enhances cardiac resistance to ischemia/reperfusion
injury and improves postischemic recovery of cardiac
function.1 Synthesis of Hsp in cardiac cells can be
induced by a variety of stimuli such as elevated tempera-
Background: Myocardial content of the 70-kd heat shock protein has been
found to correlate with improved cardiac recovery after ischemia, but the
mechanisms and conditions that regulate its level, particularly under clinical
conditions, are unclear. The aim of this study was to assess the effect of
hypothermic cardioplegic arrest and reperfusion on the expression of 70-kd
heat shock protein in a protocol mimicking conditions of preservation for
cardiac transplantation.
Methods: Heat-shocked and control hearts were subjected to 4 hours of car-
dioplegic arrest and global ischemia at 4°C and then to 20 minutes of reper-
fusion. Hearts were freeze clamped at different time points—after 15 min-
utes of Langendorff perfusion, at the end of ischemia, and after 20 minutes
of reperfusion, and analyzed for heat shock protein 70 content by Western
blotting. Another set of hearts was subjected to 10 minutes of normothermic
ischemia and 20 minutes of reperfusion followed by freeze clamping and
analysis of heat shock protein 70 content as in cardioplegic arrest protocol.
Cardiac function was measured by means of a left ventricular balloon at the
end of reperfusion.
Results: Preischemic concentration of 70-kd heat shock protein was
increased in heat-shocked hearts compared with control hearts. The content
of 70-kd heat shock protein in heat-shocked hearts was further increased
from 5.0 ± 2.4 ng/µg at the end of ischemia to 11.0 ± 4.9 ng/µg (n = 8, mean
± SD; P < .05) at 20 minutes of reperfusion after cold cardioplegic arrest. No
further rise in 70-kd heat shock protein of the heat-shocked hearts was
observed after normothermic ischemia. Maximal developed pressure was
120.8 ± 13.4 mm Hg in control hearts compared with 164.7 ± 22.5 mm Hg
in heat-shocked hearts (n = 5, mean ± SD; P = .037) after cardioplegic arrest.
By contrast, after normothermic ischemia, maximum developed pressure
was 111.2 ± 10.9 mm Hg in control hearts compared with 139.2 ± 11.0 mm
Hg in heat-shocked hearts (n = 4, mean ± SD; P = .031).
Conclusion: Hypothermic cardioplegic arrest but not short normothermic
ischemia triggered a further increase in the level of 70-kd heat shock protein
in heat-shocked rat hearts, which may enhance endogenous cardiac protec-
tion. (J Thorac Cardiovasc Surg 2001;121:1130-6)
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was found to be related to the level of Hsp contained
within the heart.9 Therefore, any additional stimulus to
increase the level of Hsp could be of clinical importance.
Cardiac cooling as a strategy for myocardial protection
is known to exert numerous effects on the cell, which can
be detrimental or beneficial; however, the net result is
cytoprotective. The effect of hypothermia on the heat
shock response has not been fully investigated. In this
present study, in which we used a protocol that mimics
donor preservation for cardiac transplantation, we inves-
tigated how hypothermic cardioplegic arrest affects
Hsp70 content in heat-shocked hearts.
Methods
Animals. Male Sprague-Dawley rats weighing between 300
and 330 g were used in all experiments. In all studies, animals
received humane care in compliance with the “Principles of
Laboratory Animal Care” formulated by the National Society
for Medical Research and the “Guide for the Care and Use of
Laboratory Animals” prepared by the Institute of Laboratory
Animal Resources, National Research Council, and published
by the National Academy Press, revised 1996.
Induction of heat shock. Rats were anesthetized with an
intraperitoneal injection of sodium pentobarbital (50 mg/kg),
then placed on a temperature-controlled heating pad (IMS K-
Temp control unit; Congleton, Cheshire, United Kingdom)
set at 45°C until body temperature reached 42°C. Body tem-
perature was monitored with a rectal temperature probe and
maintained between 42°C and 42.5°C for 15 minutes as pre-
viously described.10 The animals were left to recover for 24
hours. Control animals did not undergo this procedure.
Experimental time course. The Langendorff-perfused iso-
lated rat heart preparation used in this study has already been
described in detail elsewhere.11 In brief, all animals were put
to death by intraperitoneal injection of sodium pentobarbital
(50 mg/kg). The femoral vein was immediately exposed and
heparin (200 IU) was injected. The heart was then excised
and immediately placed in ice-cold (4°C) Krebs solution. The
aorta was rapidly cannulated (within approximately 30 sec-
onds) and Langendorff perfusion was initiated. The heart was
perfused with Krebs-Henseleit bicarbonate buffer (pH 7.4)
consisting of (in millimoles per liter) NaCl 118.5, NaHCO3
25.0, KCl 4.8, MgSO4 1.2, KH2PO4 1.2, CaCl2 1.25, and glu-
cose 11.0, which was continuously gassed with 95% oxygen
and 5% carbon dioxide and maintained at 37°C. The Krebs
buffer flowed from a reservoir 100 cm above the heart.
The heart was suspended in a water-jacketed chamber main-
tained at 37°C. After initial perfusion in the Langendorff mode,
both heat-shocked (n = 5) and control hearts (n = 5) were sub-
jected to protocol 1, including cardioplegic arrest with St
Thomas’ Hospital No. 1 cardioplegic fluid, 4 hours of global
ischemia at 4°C, and reperfusion for 20 minutes, or to protocol
2, including 10 minutes of global normothermic ischemia
(without cardioplegic arrest) at 37°C followed by 20 minutes of
reperfusion (heat-shocked hearts, n = 4; control hearts, n = 4).
Hearts were freeze clamped at different time points during both
protocols: after 15 minutes of Langendorff perfusion, at the
end of ischemia, and after 20 minutes of reperfusion.
Mechanical function was assessed with the use of a balloon
catheter inserted into the left ventricle to determine systolic
and end-diastolic pressure/volume relations after ischemia, as
previously described.11 The balloon was inflated with water in
increments of 50 µL. Left ventricular peak systolic and end-
diastolic pressures were recorded at each loading of the balloon
and were used to calculate left ventricular developed pressure
(peak systolic minus end-diastolic pressure). The diastolic
stiffness coefficient was calculated as previously described12
from the end-diastolic pressure/volume relation by logarithmic
transformation of pressure at each balloon volume. Diastolic
stiffness coefficient was the slope value of this relation. In
another series of hearts, left ventricular biopsy specimens from
control and heat stressed hearts were taken at identical time
points: after 15 minutes of Langendorff perfusion, at the end of
ischemia, after 20 minutes of reperfusion, to examine myocar-
dial Hsp70 content by Western immnoblotting (heat shocked,
n = 8, control, n = 8, cardioplegic arrest protocol; heat shocked,
n = 4-5, normothermic ischemia protocol).
Assessment of Hsp expression. The induction of Hsp70
was assessed by sodium dodecyl sulfate (SDS), poly-
acrylamide gel electrophoresis, and Western immunoblotting
as previously described.13 Whole heart homogenates were
solubilized in 1% w/v SDS and assayed for total protein
using the Bradford assay, denatured by heating at 100°C in
Laemmli buffer, and separated on 10% SDS gels until the
bromophenol blue tracking dye reached the end of the gel.
Gels were equilibrated for 30 minutes in transfer buffer, and
transfer of the proteins was performed for 1 hour at 500 mA.
Western blots were blocked with 3% w/v nonfat dried milk
(Marvel; Premier Beverages, Stafford, United Kingdom) in
phosphate-buffered saline solution containing 0.05% w/v
Tween-20 for 1 hour to block nonspecific binding sites. The
blots were then probed with mouse antibodies specific to
inducible Hsp70 (Bioquote Ltd, North Yorkshire, United
Kingdom) diluted to a final concentration of 1:1000 for 1
hour. Blots were washed 3 times and incubated with sec-
ondary horseradish-peroxidase-conjugated rabbit anti-mouse
antibody for 1 hour. The result was visualized with the use of
an enhanced chemiluminescence (ECL) detection system
(Amersham Pharmacia Biotech Inc, Piscataway, NJ).
Hyperfilm myeloperoxidase was exposed to blots treated
with ECL for 30 seconds and developed in an automatic film
processor. After ECL exposure, antibodies were removed
from blots by incubation in a solution of 2% w/v SDS, 6.25%
v/v 1 mol/L Tris hydrochloride, pH 6.8, and 0.7% v/v 2-mer-
captoethanol. Proteins were then visualized by staining with
0.01% amido black in a solution of methanol, water, and
acetic acid (ratio of 45:45:10 v/v). Amido black–stained blots
and ECL films were scanned with a Molecular Dynamics
300A laser densitometer (Molecular Dynamics, Inc, Sunny-
vale, Calif), and Hsp70 levels were determined as a propor-
tion of total protein loaded using the Quantity One software
package (PDI, Huntington, NY).
Chemicals. St Thomas’ Hospital cardioplegic solution No. 1,
supplied as concentrate (David Bull Laboratories, Mulgrave,
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Victoria, Australia), was diluted in Ringer solution (Travenol
Laboratories, Thetford, Norfolk, England) and passed through a
0.2-mm filter (Pall Biomedical, Glen Cove, NY).
Statistical analysis. Experimental results were compared
by a 1-way analysis of variance and where appropriate by a
2-way analysis of variance for repeated measures followed by
the Student t test to indicate differences between groups.
Values are presented as the mean ± SD.
Results
Cardiac Hsp70 content. The Hsp70 concentrations
at different time points of cardioplegic arrest protocol
1, in both heat-shocked and control hearts, are shown in
Fig l, A. Initial Hsp70 content was higher in heat-
shocked hearts than in control hearts. Heat-shocked
hearts subjected to 4 hours of cold cardioplegic arrest
followed by 20 minutes of reperfusion had a 2-times
greater concentration of Hsp70 than the heat-shocked
hearts after 15 minutes of Langendorff perfusion 
(P < .05) or at the end of ischemia (P < .05).
The Hsp70 levels at different time points of the nor-
mothermic ischemia protocol 2, in which both heat-
shocked and control hearts were subjected to 10 min-
utes of normothermic ischemia, are shown in Fig l, B.
The Hsp70 content was higher in all heat-shocked
hearts than in controls at their respective time points.
No further enhancement was observed on 20 minutes
of reperfusion after 10 minutes of normothermic
ischemia. The time course for the natural expression of
Hsp70 during the experimental protocol is shown in
Fig 1. A, Concentration of Hsp70 in heat-shocked and control hearts subjected to cardioplegic arrest, 4 hours of
total global ischemia at 4°C, and 20 minutes of reperfusion at various time points of the experiment: end of a 15-
minute period of initial Langendorff perfusion, end of ischemia, and 20 minutes of reperfusion. B, Concentration
of Hsp70 in heat-shocked and control hearts subjected to 10 minutes of normothermic ischemia at 37°C and 20
minutes of reperfusion at various time points of the experiment, end of a 15-minute period of initial Langendorff
perfusion, end of ischemia, and 20 minutes of reperfusion. Values represent the mean variation of sample size in
groups ± SD (n = 4-8; *P < .05 vs control at the same time point; #P < .05 vs 15 minutes of Langendorff perfu-
sion and end of ischemia).
A
B
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Fig 2. The time course of Hsp70 concentration changes after
heat stress. Values represent the mean ± SD (n = 5 in all
groups, except 29 hrs, n = 4; *P = .013 vs control; **P < .001
vs control).
Fig 3. Diastolic stiffness coefficient for heat-shocked and
control hearts subjected to cold cardioplegic arrest (n = 5) and
ischemia for 4 hours or 10 minutes of normothermic ischemia
(n = 4). Values represent the mean ± SD.
Table I. Mechanical function of heat-shocked and control hearts subjected to cardioplegic arrest for 4 hours at 4°C
Balloon volume (µL) Systolic pressure (mm Hg) Diastolic pressure (mm Hg) LVDP (mm Hg)
Control
50 55.6 ± 25.1 0.5 ± 0.6 61.0 ± 24.6
100 68.7 ± 25.5 2.1 ± 1.4 72.4 ± 24.1
150 82.4 ± 29.2 4.2 ± 2.1 85.5 ± 27.5
200 98.4 ± 30.7 6.8 ± 4.2 96.8 ± 27.1
250 112.8 ± 27.0 10.8 ± 7.8 107.6 ± 20.4
300 124.9 ± 22.7 17.2 ± 14.2 117.1 ± 12.9
Heat shock
50 66.1 ± 8.7 2.2 ± 1.3 63.9 ± 9.4
100 92.7 ± 18.9 7.5 ± 3.3 85.2 ± 16.7
150 124.1 ± 31.1 11.9 ± 6.0 112.2 ± 25.6
200 146.4 ± 31.9 20.0 ± 12.9 126.4 ± 20.1
250 177.2 ± 40.1 34.0 ± 22.5 143.2 ± 18.6
300 191.1 ± 36.1 43.1 ± 27.1 148.0 ± 14.8
LVDP, Left ventricular developed pressure.
Table II. Mechanical function of heat-shocked and control hearts subjected to 10 minutes of normothermic
ischemia at 37°C
Balloon volume (µL) Systolic pressure (mm Hg) Diastolic pressure (mm Hg) LVDP (mm Hg)
Control
50 37.7 ± 27.4 0.8 ± 0.7 36.9 ± 27.0
100 51.0 ± 36.7 1.9 ± 2.2 49.1 ± 34.9
150 63.1 ± 38.3 3.1 ± 1.1 59.9 ± 35.4
200 79.2 ± 37.1 5.0 ± 7.1 74.2 ± 31.5
250 99.8 ± 38.3 7.7 ± 11.7 92.2 ± 28.7
Heat shock
50 94.2 ± 34.8 1.4 ± 1.4 76.3 ± 34.2
100 110.2 ± 36.9 3.9 ± 2.2 90.2 ± 34.9
150 125.3 ± 36.8 6.5 ± 3.6 104.8 ± 33.6
200 137.4 ± 34.2 10.6 ± 6.1 116.9 ± 28.2
250 167.7 ± 28.7 15.6 ± 13.9 130.6 ± 14.9
LVDP, Left ventricular developed pressure.
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Fig 2. Twenty-four hours after the heat shock proce-
dure, there was an initial increase in Hsp70 expression,
which did not rise or decline over the next 5 hours.
Mechanical function. Systolic, diastolic, and devel-
oped pressures for each balloon volume are displayed
in Table I for hearts subjected to cardioplegic arrest and
in Table II for those subjected to normothermic
ischemia. The diastolic stiffness coefficients after
ischemia are displayed in Fig 3. There was no differ-
ence between the heat-shocked and the control hearts
of the 2 protocols. The left ventricular developed pres-
sures of hearts reperfused for 20 minutes after 4 hours
of hypothermic cardioplegic arrest indicated better
function in the heat-shocked hearts than in the controls,
as shown in Fig 4, A. Similarly, developed pressures for
heat-shocked and control hearts reperfused for 20 min-
utes after 10 minutes of normothermic ischemia are
displayed in Fig 4, B. The postischemic developed
pressure was significantly higher for heat-shocked
hearts than for control hearts. The maximal left ven-
tricular developed pressure for both groups was higher
for heat-shocked than for control hearts after both cold
cardioplegic and normothermic ischemia (Fig 5).
Discussion
This study demonstrates that cold cardioplegic arrest
enhanced the concentration of Hsp70 in the heat-
shocked myocardium. This rapid increase in Hsp70
content was not observed after short periods of nor-
mothermic ischemia.
Fig 4. Postischemic left ventricular developed pressure in heat-stressed and control hearts subjected to (A) 4 hours
of cold cardioplegic arrest at 4°C and reperfusion (n = 5) and (B) 10 minutes of global normothermic ischemia at
37°C and reperfusion (n = 4). Values represent the mean ± SD (*P < .05 vs control).
A
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We have previously shown that the degree of myocar-
dial protection against ischemic injury is proportional to
the concentration of Hsp70. Both cardiac output and
endothelial function were improved when the time inter-
val between heat shock and the onset of ischemia ranged
from 24 to 30 hours. Analysis of Hsp70 expression
showed maximal levels at 24 hours, which correlated
with better mechanical function.9 Therefore, this
enhanced level of Hsp70 after hypothermia may con-
tribute to the endogenous protective mechanisms of the
heart. The data showing the natural time course of Hsp70
after heat shock confirm that this raised level of Hsp70
can be attributed to hypothermic cardioplegic arrest, inas-
much as the experiment without cardioplegic arrest
shows no subsequent rise in Hsp70 expression. A further
increase in the level of Hsp70 was not observed after nor-
mothermic ischemia and reperfusion. This suggests that
prolonged hypothermic ischemia plays a vital role in this
phenomenon to a greater extent than either ischemia or
reperfusion. The increase in Hsp70 after hypothermic
ischemia was observed within 20 minutes of reperfusion.
The short time interval required for the presence of this
enhanced level of Hsp70 suggests that this protein may
not necessarily be the result of gene transcription or trans-
lation. However, heat shock genes are unusual in that they
do not contain any introns or intervening sequences,
allowing for rapid transcription of the gene and messen-
ger RNA processing. In response to intracellular stress,
the synthesis of genes containing introns is inhibited.
Because of the lack of introns in hsp genes, replication of
the active hsp mRNA genes is quickly facilitated, which
is essential for rapid deployment of the protein.14
Rapid expression of Hsp70 has been documented by
Liu and associates,15 demonstrating the presence of
Hsp70 within 15 minutes after the onset of heat shock
pretreatment, which showed a notable increase after 1
hour of reperfusion. Han and colleagues16 demonstrat-
ed a rapid 46% increase in Hsp70 levels within 20 min-
utes in cells continuously exposed to magnetic fields.
Demidov and coworkers17 observed an increase in
Hsp70 levels in the right atria of patients after car-
diopulmonary bypass; the postbypass level of Hsp70
was highest when the duration of cardioplegic arrest
was greater than 2 hours. Clarification of the mecha-
nisms responsible for the rapid expression of stress pro-
teins is an important challenge if the observed effects
are to be fully explained. The use of hypothermia for
organ preservation is based on a reduction in metabol-
ic rate.18 Although the effects of hypothermia can be
both damaging and beneficial, the net result on
ischemic tissue is protective. Myocardial hypothermia
reduces the energy requirements of the organ by
depressing mechanical, electrical, and metabolic activ-
ity. This protective effect is potentiated by the addition
of hyperkalemic cardioplegia.18 In conclusion, the
results of this study show that hypothermic cardio-
plegic arrest is capable of inducing Hsp70 in the heat-
shocked heart; however, the exact mechanisms have yet
to be identified. Our findings highlight an additional
pathway for the protective effect of hypothermic car-
dioplegic arrest.
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Notice of correction
In the May 2001 issue of the Journal, in the article by Fiser and associates titled “Aerosolized Prostacyclin 
(Epoprostenol) as an Alternative to Inhaled Nitric Oxide for Patients With Reperfusion Injury After Lung
Transplantation” (2001;121:981-2), an error was made. On page 981 the name of one author, Stuart M. Lowson,
MD, was omitted. The correct listing of authors is available online at www.mosby.com/jtcvs.
